Your browser doesn't support javascript.
loading
A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection.
Elamin, Ayssar A; Klunkelfuß, Saskia; Kämpfer, Susanne; Oehlmann, Wulf; Stehr, Matthias; Smith, Christopher; Simpson, Guy R; Morgan, Richard; Pandha, Hardev; Singh, Mahavir.
Affiliation
  • Elamin AA; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
  • Klunkelfuß S; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
  • Kämpfer S; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
  • Oehlmann W; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
  • Stehr M; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
  • Smith C; Department of Oncology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
  • Simpson GR; Department of Oncology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
  • Morgan R; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, United Kingdom.
  • Pandha H; Department of Oncology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
  • Singh M; LIONEX Diagnostics and Therapeutics GmbH, Brunswick, Germany.
Front Oncol ; 9: 1484, 2019.
Article in En | MEDLINE | ID: mdl-31993369
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Front Oncol Year: 2019 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Front Oncol Year: 2019 Type: Article Affiliation country: Germany